Fig. 4From: Qualitative interviews of patients with COPD and muscle weakness enrolled in a clinical trial evaluating a new anabolic treatment: patient perspectives of disease experience, trial participation and outcome assessmentsOverview of changes in (A) symptoms and (B) functional limitations during the triala. aReported by participants during the 60-minute (n = 32) and 15-minute interviews (n = 35). No positive response included participants who either mentioned that there was no change or did not specifically comment on whether they had experienced a changeBack to article page